Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Esophageal mucosal injury with low-dose aspirin and its prevention by rabeprazole.

Journal of clinical pharmacology - 1 Mar 2010

Sugimoto Mitsushige, Nishino Masafumi, Kodaira Chise, Yamade Mihoko, Ikuma Mutsuhiro, Tanaka Tatsuo, Sugimura Haruhiko, Hishida Akira, Furuta Takahisa

Abstract excerpt

Aspirin is used widely as an antithrombotic drug for the prevention of cardiovascular and cerebrovascular events. Although aspirin increases the risk for gastrointestinal mucosal injury, the effect on esophageal mucosa is unclear. This study investigates whether aspirin induces esophageal mucosal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 2-Pyridinylmethylsulfinylbenzimidazoles
Share to Anti-Inflammatory Agents, Non-Steroidal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anti-Ulcer Agents

Share to Aspirin

Share to Cross-Over Studies

Share to Gastric Mucosa

Share to Gastroesophageal Reflux

Share to Rabeprazole

Source

Identifiers

PMID: 19940233
DOI: 10.1177/0091270009344983

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19940233-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Esophageal mucosal injury with low-dose aspirin and its prevention by rabeprazole.PMID 19940233Read ↗

Ability of rabeprazole to prevent gastric mucosal damage from clopidogrel and low doses of aspirin depends on CYP2C19 genotype.Semantic proximity Read ↗

Antiplatelet drugs are a risk factor for esophageal mucosal injury.Semantic proximity Read ↗

Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine.Semantic proximity Read ↗

Relationship between low-dose aspirin-induced gastric mucosal injury and intragastric pH in healthy volunteers.Semantic proximity Read ↗

Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.Semantic proximity Read ↗

Study of Clinical and Genetic Risk Factors for Aspirin-induced Gastric Mucosal Injury.Semantic proximity Read ↗

Risk and preventive factors of low-dose aspirin-induced gastroduodenal injuries: a comprehensive review.Semantic proximity Read ↗

The influence of CYP2C19 polymorphisms on exacerbating effect of rabeprazole in celecoxib-induced small bowel injury.Semantic proximity Read ↗

Effect of a rabeprazole half-dose twice daily on acid inhibition in patients with different CYP2C19 alleles.Semantic proximity Read ↗

Proton pump inhibitors and recurrent bleeding in peptic ulcer disease.Semantic proximity Read ↗

Gastroesophageal Reflux Disease.Semantic proximity Read ↗

Endoscopic analysis of gastric ulcer after one week's treatment with omeprazole and rabeprazole in relation to CYP2C19 genotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.